BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 25973198)

  • 1. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy.
    Fumagalli G; Fabiani F; Forte S; Napolitano M; Balzano G; Bonini M; De Simone G; Fuschillo S; Pentassuglia A; Pasqua F; Alimonti P; Carlone S; Sanguinetti CM
    Multidiscip Respir Med; 2015; 10(1):4. PubMed ID: 25973198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. INDACO project: a pilot study on incidence of comorbidities in COPD patients referred to pneumology units.
    Fumagalli G; Fabiani F; Forte S; Napolitano M; Marinelli P; Palange P; Pentassuglia A; Carlone S; Sanguinetti CM
    Multidiscip Respir Med; 2013 Apr; 8(1):28. PubMed ID: 23551874
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapy with proton-pump inhibitors for gastroesophageal reflux disease does not reduce the risk for severe exacerbations in COPD.
    Baumeler L; Papakonstantinou E; Milenkovic B; Lacoma A; Louis R; Aerts JG; Welte T; Kostikas K; Blasi F; Boersma W; Torres A; Rohde GG; Boeck L; Rakic J; Scherr A; Tamm M; Stolz D
    Respirology; 2016 Jul; 21(5):883-90. PubMed ID: 26970108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Exacerbations and Lung Function Loss in Smokers with and without Chronic Obstructive Pulmonary Disease.
    Dransfield MT; Kunisaki KM; Strand MJ; Anzueto A; Bhatt SP; Bowler RP; Criner GJ; Curtis JL; Hanania NA; Nath H; Putcha N; Roark SE; Wan ES; Washko GR; Wells JM; Wendt CH; Make BJ;
    Am J Respir Crit Care Med; 2017 Feb; 195(3):324-330. PubMed ID: 27556408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COPD-X Australian and New Zealand guidelines for the diagnosis and management of chronic obstructive pulmonary disease: 2017 update.
    Yang IA; Brown JL; George J; Jenkins S; McDonald CF; McDonald VM; Phillips K; Smith BJ; Zwar NA; Dabscheck E
    Med J Aust; 2017 Nov; 207(10):436-442. PubMed ID: 29129177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.
    Rubinsztajn R; Przybyłowski T; Grabicki M; Karwat K; Maskey-Warzęchowska M; Batura-Gabryel H; Chazan R
    Adv Clin Exp Med; 2019 Mar; 28(3):319-324. PubMed ID: 30943332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of different comorbidities in COPD patients by gender and GOLD stage.
    Dal Negro RW; Bonadiman L; Turco P
    Multidiscip Respir Med; 2015; 10(1):24. PubMed ID: 26246895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A self-management approach using self-initiated action plans for symptoms with ongoing nurse support in patients with Chronic Obstructive Pulmonary Disease (COPD) and comorbidities: the COPE-III study protocol.
    Lenferink A; Frith P; van der Valk P; Buckman J; Sladek R; Cafarella P; van der Palen J; Effing T
    Contemp Clin Trials; 2013 Sep; 36(1):81-9. PubMed ID: 23770110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of comorbidities in COPD patients by disease severity in a German population.
    Greulich T; Weist BJD; Koczulla AR; Janciauskiene S; Klemmer A; Lux W; Alter P; Vogelmeier CF
    Respir Med; 2017 Nov; 132():132-138. PubMed ID: 29229085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Plasma Heat Shock Protein 70 with Disease Severity, Smoking and Lung Function of Patients with Chronic Obstructive Pulmonary Disease.
    Hlapčić I; Hulina-Tomašković A; Grdić Rajković M; Popović-Grle S; Vukić Dugac A; Rumora L
    J Clin Med; 2020 Sep; 9(10):. PubMed ID: 32992869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical and integrated management of COPD.
    Bettoncelli G; Blasi F; Brusasco V; Centanni S; Corrado A; De Benedetto F; De Michele F; Di Maria GU; Donner CF; Falcone F; Mereu C; Nardini S; Pasqua F; Polverino M; Rossi A; Sanguinetti CM
    Sarcoidosis Vasc Diffuse Lung Dis; 2014 May; 31 Suppl 1():3-21. PubMed ID: 24820963
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The associations between comorbidity and exacerbation risk in patients with chronic obstructive pulmonary disease].
    Huang YL; Mao B; Mim J; Li GH; Zheng YQ; Wu LH; Wang SJ; Qu B; Fu JJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2018 May; 41(5):349-354. PubMed ID: 29747278
    [No Abstract]   [Full Text] [Related]  

  • 13. Sex Differences in Veterans Admitted to the Hospital for Chronic Obstructive Pulmonary Disease Exacerbation.
    Bade BC; DeRycke EC; Ramsey C; Skanderson M; Crothers K; Haskell S; Bean-Mayberry B; Brandt C; Bastian LA; Akgün KM
    Ann Am Thorac Soc; 2019 Jun; 16(6):707-714. PubMed ID: 30822098
    [No Abstract]   [Full Text] [Related]  

  • 14. Determining prognosis in acute exacerbation of COPD.
    Flattet Y; Garin N; Serratrice J; Perrier A; Stirnemann J; Carballo S
    Int J Chron Obstruct Pulmon Dis; 2017; 12():467-475. PubMed ID: 28203070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Major comorbidities lead to the risk of adverse cardiovascular events in chronic obstructive pulmonary disease patients using inhaled long-acting bronchodilators: a case-control study.
    Chen YF; Cheng YC; Chou CH; Chen CY; Yu CJ
    BMC Pulm Med; 2019 Dec; 19(1):233. PubMed ID: 31795986
    [TBL] [Abstract][Full Text] [Related]  

  • 16. COPD exacerbations associated with the modified Medical Research Council scale and COPD assessment test among Humana Medicare members.
    Pasquale MK; Xu Y; Baker CL; Zou KH; Teeter JG; Renda AM; Davis CC; Lee TC; Bobula J
    Int J Chron Obstruct Pulmon Dis; 2016; 11():111-21. PubMed ID: 26834468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Airflow Obstruction and Cardio-metabolic Comorbidities.
    Triest FJJ; Studnicka M; Franssen FME; Vollmer WM; Lamprecht B; Wouters EFM; Burney PGJ; Vanfleteren LEGW
    COPD; 2019 Apr; 16(2):109-117. PubMed ID: 31131642
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis on respiratory rehabilitation in patients with chronic obstructive pulmonary disease aged 40 years or older in China, 2014-2015].
    Cong S; Wang N; Fan J; Wang BH; Bao HL; Lyu XL; Feng YJ; Yang T; Wang LH; Fang LW
    Zhonghua Liu Xing Bing Xue Za Zhi; 2020 Jul; 41(7):1014-1020. PubMed ID: 32741163
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of COPD severity and comorbidities on the result of the PHQ-9 tool for the diagnosis of depression: results from the COSYCONET cohort study.
    von Siemens SM; Jörres RA; Behr J; Alter P; Lutter J; Lucke T; Söhler S; Welte T; Watz H; Vogelmeier CF; Trudzinski F; Rief W; Herbig B; Kahnert K;
    Respir Res; 2019 Feb; 20(1):30. PubMed ID: 30744630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the presence of bronchiectasis and acute exacerbation in Thai COPD patients.
    Kawamatawong T; Onnipa J; Suwatanapongched T
    Int J Chron Obstruct Pulmon Dis; 2018; 13():761-769. PubMed ID: 29535516
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.